BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $204,000 | -17.7% | 2,628 | -8.9% | 0.02% | -15.8% |
| Q4 2021 | $248,000 | +6.9% | 2,885 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $232,000 | -3.7% | 2,885 | -3.7% | 0.02% | -5.0% |
| Q2 2021 | $241,000 | -4.7% | 2,995 | 0.0% | 0.02% | -13.0% |
| Q1 2021 | $253,000 | -19.7% | 2,995 | -23.8% | 0.02% | -23.3% |
| Q4 2020 | $315,000 | -7.9% | 3,930 | -7.6% | 0.03% | -14.3% |
| Q3 2020 | $342,000 | -18.2% | 4,255 | -12.4% | 0.04% | -23.9% |
| Q2 2020 | $418,000 | -5.0% | 4,855 | -10.5% | 0.05% | -19.3% |
| Q1 2020 | $440,000 | -35.8% | 5,423 | -33.8% | 0.06% | -20.8% |
| Q4 2019 | $685,000 | -14.3% | 8,186 | -10.4% | 0.07% | -19.1% |
| Q3 2019 | $799,000 | +3.9% | 9,136 | -2.7% | 0.09% | +1.1% |
| Q2 2019 | $769,000 | -1.4% | 9,386 | -2.2% | 0.09% | -5.4% |
| Q1 2019 | $780,000 | +23.8% | 9,595 | +0.2% | 0.09% | +14.8% |
| Q4 2018 | $630,000 | -14.6% | 9,578 | 0.0% | 0.08% | -2.4% |
| Q3 2018 | $738,000 | -11.3% | 9,578 | -15.0% | 0.08% | -16.2% |
| Q2 2018 | $832,000 | +4.9% | 11,269 | -7.6% | 0.10% | +6.5% |
| Q1 2018 | $793,000 | -32.2% | 12,194 | -32.6% | 0.09% | -32.1% |
| Q4 2017 | $1,170,000 | +3.0% | 18,103 | 0.0% | 0.14% | -0.7% |
| Q3 2017 | $1,136,000 | -2.9% | 18,103 | -6.3% | 0.14% | -6.8% |
| Q2 2017 | $1,170,000 | -18.8% | 19,319 | -30.5% | 0.15% | -20.0% |
| Q1 2017 | $1,441,000 | +2.1% | 27,792 | -12.7% | 0.18% | -3.6% |
| Q4 2016 | $1,412,000 | – | 31,842 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |